Inflammation Markers: hs-CRP and Aging

Aging researchers increasingly talk about “inflammaging” — the low-grade, chronic inflammation that tends to creep upward as we get older and that correlates with many age-related diseases. It’s an appealing concept, and it raises a practical question: can you actually measure it? One widely available blood test, high-sensitivity C-reactive protein (hs-CRP), comes up most often. It’s useful, with real caveats worth understanding.

What hs-CRP is measuring

C-reactive protein is produced by the liver in response to inflammation. The “high-sensitivity” version can detect the low concentrations relevant to chronic, smoldering inflammation rather than the dramatic spikes of an acute infection. Because chronic low-grade inflammation is woven through the biology of cardiovascular disease, metabolic dysfunction, and aging more broadly, hs-CRP serves as a convenient, inexpensive window onto it.

The key framing: hs-CRP is a signal, not a diagnosis. An elevated reading says inflammation is present somewhere — it doesn’t say why, and a single value can be misleading.

The caveats that matter

hs-CRP is non-specific, which is its main limitation:

• It spikes with acute illness. A cold, an injury, or a recent infection can transiently raise it, so one reading taken at the wrong time misleads. Trends across multiple measurements are more informative than a single number.
• Many things move it. Body fat, smoking, poor sleep, and other conditions all influence it, so it reflects general inflammatory state rather than any one cause.
• It’s associative. Elevated hs-CRP travels with worse outcomes in large studies, but lowering the number is not automatically the same as lowering risk — the marker may be reporting a problem rather than being the problem itself.

What a landmark trial actually showed

The clearest evidence that hs-CRP carries information comes from JUPITER, published in the New England Journal of Medicine in 2008. It enrolled 17,802 apparently healthy people with normal LDL cholesterol (under 130 mg/dL) but elevated hs-CRP (2 mg/L or higher) and randomized them to rosuvastatin 20 mg or placebo.

In JUPITER, treating people selected by high hs-CRP cut first major cardiovascular events by 44% (hazard ratio 0.56) and all-cause death by 20% — and the trial was stopped early for benefit. Rosuvastatin lowered hs-CRP by about 37%.

That result made hs-CRP a respectable risk-stratification tool. What it does not prove is that hs-CRP causes events: statins lower cholesterol, inflammation, and other factors at once, so the trial can’t isolate “lowering CRP” as the active ingredient. hs-CRP remains, in the trial authors’ framing, a risk marker rather than an established causal target.

How to think about it for aging

As a longevity tool, hs-CRP is best treated as one input among several, useful for spotting a pattern over time. Persistently elevated levels are a reasonable prompt to look at the modifiable drivers — fitness, body composition, sleep, smoking — that genuinely influence chronic inflammation. The honest limit is that we should be cautious about treating the number itself as the target; the goal is the underlying health it partly reflects.

A cheaper and more widely available inflammation proxy sits on the same panel — see what white blood cell count says about aging.

Reading an hs-CRP result

hs-CRP	Conventional reading	What it does not tell you
< 1 mg/L	Lower relative cardiovascular risk	Why it is low
1–3 mg/L	Average relative risk	Whether it is stable
> 3 mg/L	Higher relative risk	The source of the inflammation
> 10 mg/L	Usually acute — infection, injury, flare	Almost never a chronic-risk reading

The last row is the one people misread. A value above 10 mg/L generally reflects something happening now rather than a long-run risk profile, which is why a single measurement taken during a cold or after hard training says very little.

Frequently asked questions

What is hs-CRP?

A high-sensitivity measurement of C-reactive protein, a liver-produced marker that rises with inflammation. The “high-sensitivity” part matters: it resolves the low range where cardiovascular risk gradients appear, which a standard CRP test cannot.

What is a good hs-CRP level?

Conventionally under 1 mg/L is the lower-risk band and over 3 mg/L the higher-risk one. Those are population risk gradients rather than a diagnosis, and a single value can mislead.

Does high hs-CRP mean I have heart disease?

No. It says inflammation is present somewhere. It does not say why, and infection, injury, recent hard exercise, and autoimmune flares all raise it. Persistent elevation across repeat measurements is more informative than any one reading.

Can you lower hs-CRP?

JUPITER is the relevant evidence, and worth reading carefully: treating people selected by high hs-CRP cut first major cardiovascular events by 44% (hazard ratio 0.56) and all-cause death by 20%, and the trial stopped early for benefit. That tested a drug in a selected population — it is not a demonstration that lowering the number by any means produces the same result.

How often should hs-CRP be tested?

Rarely enough to avoid chasing noise, and never during or just after an acute illness. Because a single value is unreliable, the useful pattern is repeat measurement under comparable conditions.

The takeaway

hs-CRP is a cheap, accessible marker of the chronic inflammation that tracks with aging and disease, and that makes it genuinely useful — as a trend, interpreted in context, not as a one-off verdict. Read it as a smoke detector: a high reading is a reason to look for the source, not proof of any specific fire, and certainly not a number to chase for its own sake.

Sources

• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein — JUPITER (NEJM, 2008)
• C-Reactive Protein: How Has JUPITER Impacted Clinical Practice? (PMC review)